Condition
Bietti Crystalline Dystrophy
Total Trials
4
Recruiting
1
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Early P 1 (1)
P 1 (1)
P 3 (2)
Trial Status
Active Not Recruiting2
Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06699108Phase 3Active Not RecruitingPrimary
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
NCT05694598Phase 1Active Not RecruitingPrimary
Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy
NCT06743646Phase 3Recruiting
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT05399069Early Phase 1UnknownPrimary
Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy
Showing all 4 trials